| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017514052 |
| P356 | DOI | 10.1038/CR.2014.32 |
| P932 | PMC publication ID | 4042166 |
| P698 | PubMed publication ID | 24638034 |
| P5875 | ResearchGate publication ID | 260875383 |
| P50 | author | Jian Zhao | Q52683278 |
| P2093 | author name string | Min Wang | |
| Gang Pei | |||
| Lin Cheng | |||
| Binlong Qiu | |||
| Wenxiang Hu | |||
| Wuqiang Guan | |||
| Wuzhou Yang | |||
| Yongchun Yu | |||
| P2860 | cites work | Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels | Q24295157 |
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Sheep cloned by nuclear transfer from a cultured cell line | Q28275874 | ||
| Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system | Q28292445 | ||
| Direct isolation of human central nervous system stem cells | Q28318408 | ||
| Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells | Q28366303 | ||
| A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube | Q28593188 | ||
| Epigenetic memory in induced pluripotent stem cells | Q29547892 | ||
| Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds | Q29614344 | ||
| Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 | ||
| Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds | Q29616608 | ||
| Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors | Q30514064 | ||
| Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds | Q33382569 | ||
| A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog | Q33509682 | ||
| E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation | Q33593325 | ||
| Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia | Q33798508 | ||
| Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc | Q34019451 | ||
| Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy | Q34025541 | ||
| Activation of innate immunity is required for efficient nuclear reprogramming | Q34034126 | ||
| Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 | ||
| Direct lineage conversions: unnatural but useful? | Q34224069 | ||
| Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei | Q34244306 | ||
| Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 | ||
| Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 | ||
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor | Q34280164 | ||
| Generation of human induced pluripotent stem cells from urine samples. | Q34310664 | ||
| Conversion of human fibroblasts to angioblast-like progenitor cells | Q34314865 | ||
| Generation of integration-free neural progenitor cells from cells in human urine | Q34316451 | ||
| Stimulus-triggered fate conversion of somatic cells into pluripotency | Q34400857 | ||
| Identification of Oct4-activating compounds that enhance reprogramming efficiency | Q34501513 | ||
| Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors | Q36212351 | ||
| The therapeutic potential of neural stem cells | Q36500191 | ||
| Preferential electrical coupling regulates neocortical lineage-dependent microcircuit assembly | Q36690729 | ||
| Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche | Q37777514 | ||
| Pluripotent teratocarcinoma-thymus somatic cell hybrids | Q39403311 | ||
| Neural progenitors from human embryonic stem cells. | Q40673316 | ||
| Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. | Q41080686 | ||
| Stem cells in the central nervous system | Q41116811 | ||
| Cytoplasmic activation of human nuclear genes in stable heterocaryons | Q42799501 | ||
| Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. | Q42971176 | ||
| Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency | Q44553011 | ||
| Tracking neural stem cells in patients with brain trauma | Q48352456 | ||
| Nested expression domains of four homeobox genes in developing rostral brain | Q48444447 | ||
| Distributions of PAX6 and PAX7 proteins suggest their involvement in both early and late phases of chick brain development | Q48640471 | ||
| Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. | Q49159036 | ||
| Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. | Q51066733 | ||
| Isolating, expanding, and infecting human and rodent fetal neural progenitor cells. | Q51948685 | ||
| Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. | Q52249431 | ||
| Zic3 induces conversion of human fibroblasts to stable neural progenitor-like cells | Q56777673 | ||
| Hypoxia enhances the generation of induced pluripotent stem cells | Q84487554 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 665-679 | |
| P577 | publication date | 2014-03-18 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Generation of neural progenitor cells by chemical cocktails and hypoxia | |
| P478 | volume | 24 |
| Q40188915 | A chemical approach to "rewire" neural progenitor cells |
| Q89927051 | A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations |
| Q55093717 | Adult Neural Stem Cells: Basic Research and Production Strategies for Neurorestorative Therapy. |
| Q90249299 | Advances in Transcription Factors Related to Neuroglial Cell Reprogramming |
| Q26775122 | An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs |
| Q92535105 | Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases |
| Q39018397 | Brief azacytidine step allows the conversion of suspension human fibroblasts into neural progenitor-like cells. |
| Q26768123 | Cardiomyocyte generation from somatic sources - current status and future directions |
| Q38730766 | Cell fate modification toward the hepatic lineage by extrinsic factors. |
| Q92541398 | Chemical Cocktail Induces Hematopoietic Reprogramming and Expands Hematopoietic Stem/Progenitor Cells |
| Q41327333 | Chemical Cocktails Enable Hepatic Reprogramming of Mouse Fibroblasts with a Single Transcription Factor |
| Q64249232 | Chemical Conversion of Human Fetal Astrocytes into Neurons through Modulation of Multiple Signaling Pathways |
| Q54217784 | Chemical compound-based direct reprogramming for future clinical applications. |
| Q38824819 | Chemical transdifferentiation: closer to regenerative medicine |
| Q26767244 | Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells |
| Q26739987 | Chemicals as the Sole Transformers of Cell Fate |
| Q101133342 | Chemicals orchestrate reprogramming with hierarchical activation of master transcription factors primed by endogenous Sox17 activation |
| Q37712423 | Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury |
| Q52638891 | Concise Review: Stem Cell Fate Guided By Bioactive Molecules for Tendon Regeneration. |
| Q36805048 | Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor. |
| Q90417308 | Conversion of human urine-derived cells into neuron-like cells by small molecules |
| Q44784006 | Current progress in the derivation and therapeutic application of neural stem cells. |
| Q37707499 | Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules |
| Q43167160 | Direct conversion of astrocytes into neuronal cells by drug cocktail |
| Q38411899 | Direct lineage conversion of astrocytes to induced neural stem cells or neurons |
| Q35577343 | Direct reprogramming of induced neural progenitors: a new promising strategy for AD treatment |
| Q30663690 | Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails |
| Q37708086 | Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts. |
| Q38953420 | Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications |
| Q38640670 | Erase and Rewind: Epigenetic Conversion of Cell Fate |
| Q90319236 | Evolving principles underlying neural lineage conversion and their relevance for biomedical translation |
| Q34684538 | Fast and efficient neural conversion of human hematopoietic cells |
| Q91614573 | Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury |
| Q26765258 | Generation of diverse neural cell types through direct conversion |
| Q90296223 | Generation of dopamine neuronal-like cells from induced neural precursors derived from adult human cells by non-viral expression of lineage factors |
| Q38700229 | Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish |
| Q39003757 | Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). |
| Q89831603 | High-Resolution Dissection of Chemical Reprogramming from Mouse Embryonic Fibroblasts into Fibrocartilaginous Cells |
| Q35678981 | Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds |
| Q41235564 | Human somatic cells acquire the plasticity to generate embryoid-like metamorphosis via the actin cytoskeleton in injured tissues |
| Q90733813 | Impelling force and current challenges by chemicals in somatic cell reprogramming and expansion beyond hepatocytes |
| Q37600465 | Induced dopaminergic neurons: A new promise for Parkinson's disease |
| Q38528543 | Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases |
| Q28547193 | Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach |
| Q38930831 | In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells |
| Q47201757 | Linking invasive motility to protein expression in single tumor cells |
| Q92087780 | Long-term expansion of directly reprogrammed keratinocyte-like cells and in vitro reconstitution of human skin |
| Q40061010 | Methods of reactivation and reprogramming of neural stem cells for neural repair |
| Q48160741 | Neural Crest Stem-Like Cells Non-genetically Induced from Human Gingiva-Derived Mesenchymal Stem Cells Promote Facial Nerve Regeneration in Rats |
| Q33722523 | Neural Progenitor-Like Cells Induced from Human Gingiva-Derived Mesenchymal Stem Cells Regulate Myelination of Schwann Cells in Rat Sciatic Nerve Regeneration. |
| Q27021719 | Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases |
| Q38668995 | Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery. |
| Q38609711 | New approaches for direct conversion of patient fibroblasts into neural cells |
| Q51521260 | Oxygen and differentiation status modulate the effect of X-ray irradiation on physiology and mitochondrial proteome of human neuroblastoma cells. |
| Q41458562 | Paying the Toll in Nuclear Reprogramming |
| Q53412714 | Physiological Hypoxia Enhances Stemness Preservation, Proliferation, and Bidifferentiation of Induced Hepatic Stem Cells. |
| Q37014278 | Physiological, pathological, and engineered cell identity reprogramming in the central nervous system |
| Q88769622 | Pluripotent stem cells: induction and self-renewal |
| Q57035154 | Potential application of cell reprogramming techniques for cancer research |
| Q35761135 | Probing disorders of the nervous system using reprogramming approaches |
| Q26750951 | Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells |
| Q90681710 | Regenerative medicine: could Parkinson's be the first neurodegenerative disease to be cured? |
| Q50322422 | Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease |
| Q38798149 | Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion |
| Q33628088 | Reprogramming cell fates by small molecules |
| Q26853155 | Reprogramming cells with synthetic proteins |
| Q47645196 | Reprogramming of somatic cells to induced neural stem cells |
| Q36416719 | Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo. |
| Q33742361 | Sequential EMT-MET induces neuronal conversion through Sox2. |
| Q36363089 | Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons |
| Q54161835 | Small molecule-induced cellular conversion. |
| Q38658879 | Small molecules for reprogramming and transdifferentiation |
| Q89811163 | Small-molecule-mediated reprogramming: a silver lining for regenerative medicine |
| Q64065428 | Suppression of glioblastoma by a drug cocktail reprogramming tumor cells into neuronal like cells |
| Q99583681 | The combination of forskolin and VPA increases gene expression efficiency to the hypoxia/neuron-specific system |
| Q28079389 | The quest for an effective and safe personalized cell therapy using epigenetic tools |
| Q91711175 | Therapeutic Plasticity of Neural Stem Cells |
| Q92972601 | Transcriptome Analysis of Small Molecule-Mediated Astrocyte-to-Neuron Reprogramming |
| Q59813436 | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
| Q58799682 | Transdifferentiation: a new promise for neurodegenerative diseases |
| Q64236248 | Trichostatin A Promotes the Conversion of Astrocytes to Oligodendrocyte Progenitors in a Defined Culture Medium |
| Q39085008 | Understanding Parkinson's Disease through the Use of Cell Reprogramming |
| Q55715290 | Urine-derived cells for human cell therapy. |
| Q42949002 | Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells |
| Q90263455 | Valproic Acid Enhances Reprogramming Efficiency and Neuronal Differentiation on Small Molecules Staged-Induction Neural Stem Cells: Suggested Role of mTOR Signaling |
| Q93141072 | mRNA-Driven Generation of Transgene-Free Neural Stem Cells from Human Urine-Derived Cells |
Search more.